Searched for
E GENERIC VERSION OF SANOFI AVENTIS
Why do we think everyone is judging us? Psychology explains the Spotlight Effect and why we feel constantly observedPsychology reveals we often overestimate how much others notice our flaws, a phenomenon known as the Spotlight Effect. Our egocentric persp...- Psychology says people who are never happy with their haircuts may be noticing more than just their appearance, their brains may be noticing every tiny detailPsychology says people who are rarely satisfied with their haircuts may be affected by expectation bias, self-discrepancy theory, loss aver...
- Tata Sierra EV launched at Rs 18.79 lakh with QWD, fast charging, lifetime battery warranty and moreTata Sierra EV launched: Tata Motors has launched the Sierra EV in India, bringing quad wheel drive, a triple-screen cabin, six terrain mod...
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
- Tata Sierra EV launch today: Check price, features, battery options and other key featuresTata Motors is launching the highly anticipated Sierra EV today, June 30, in an all-new electric avatar. Teasers reveal a potential driving...
- Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...
- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Agility Robotics heads to Wall Street in a $2.5 billion bet on staffing warehouses with humanoidsAgility Robotics, an AI-driven humanoid robotics for warehouse operations, plans to go public with a remarkable $2.5 billion valuation. Thi...
- Anthropic launches Claude Tag: Everything you need to know about the Slack-native AI agentAI startup Anthropic has launched Claude Tag, a new Slack-native AI experience, replacing its previous chatbot. This "inline" agent seamles...
- Tata Sierra EV teaser released: Check launch date, battery options, interior design and other key featuresTata Motors is building anticipation for its upcoming Sierra EV, set to launch in India on June 30. A recent teaser showcases the electric ...
- Tata Sierra EV teased with QWD dual motor setup; Check expected powertrain, interior & rivalsTata Sierra EV AWD confirmed: Tata Motors has teased the Sierra EV ahead of its June 30 debut, confirming that the electric SUV will get a ...
- Aadhaar email update to be free via mobile app from July 1; UIDAI waives Rs 75 fee for six monthsThe Unique Identification Authority of India (UIDAI) is making email address updates via the Aadhaar mobile app free for six months, from J...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
Load More
